Kenneth Ataga

Division Chief, College of Medicine, Medicine, Med Hematology & Oncology. · University of Tennessee College of Medicine

Credentials: · · · ·

History

Teaching Scholars Program (Fellowship), University of North Carolina at Chapel Hill. Chapel Hill, NC, United States. (September 2004 - August
1993–1994
University of North Carolina at Chapel Hill.
SUNY Health Science Center (currently Upstate Medical University) at Syracuse
1990–1993
Received), University of Tennessee Health
UNIV OF BENIN, COLL OF MED SCI, BENIN CITY, NIGERIA
1986–1990

Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.2M · University of Tennessee Health Sci Ctr
2021–2026
The Association of Biomarkers of Endothelial Function with Prospective Changes in Kidney Function in Sickle Cell Anemia
Food and Drug Administration · R01
Contact PI · $2M · University of Tennessee Health Sci Ctr
2017–2023
Targeted Anticoagulant Therapy for Sickle Cell Disease
National Heart, Lung, and Blood Institute · U01
Contact PI · $6.1M · Univ of North Carolina Chapel Hill
2013–2018
Endothelial Dysfunction in the Pathogenesis of Sickle Cell Nephropathy
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.3M · Univ of North Carolina Chapel Hill
2012–2017

The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
Principal investigator · Unknown
University of Tennessee
2022–2026
Kidney Function in Sickle Cell Anemia
Principal investigator · Active not recruiting
Kenneth Ataga MD
2017–2025
Hepcidin Levels in Sickle Cell Disease (SCD)
Principal investigator · Completed
Kenneth Ataga, MD
2014–2015
The Effect of Rivaroxaban in Sickle Cell Disease
Principal investigator · Completed · Phase 2
University of North Carolina, Chapel Hill
2014–2018